Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders
- PMID: 15172939
- DOI: 10.1192/bjp.184.6.470
Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders
Abstract
Background: General practitioners play a pivotal part in the recognition and treatment of psychiatric disorders. Identifying somatoform disorders is important for the choice of treatment.
Aims: To quantify the prevalence of, and functional impairment associated with, somatoform disorders, and their comorbidity with anxiety/depressive disorders.
Method: Two-stage prevalence study: a set of questionnaires was completed by 1046 consecutive patients of general practitioners (aged 25-80 years), followed by a standardised diagnostic interview (SCAN 2.1).
Results: The prevalence of somatoform disorders was 16.1% (95% CI 12.8-19.4). When disorders with only mild impairment were included, the prevalence increased to 21.9%. Comorbidity of somatoform disorders and anxiety/depressive disorders was 3.3 times more likely than expected by chance. In patients with comorbid disorders, physical symptoms, depressive symptoms and functional limitations were additive.
Conclusions: Our findings underline the importance of a comprehensive diagnostic approach to psychiatric disorders in general practice.
Comment in
-
Somatoform disorders: a help or hindrance to good patient care?Br J Psychiatry. 2004 Jun;184:465-7. doi: 10.1192/bjp.184.6.465. Br J Psychiatry. 2004. PMID: 15172937 No abstract available.
Similar articles
-
[Somatoform disorders in general practice: prevalence, functional limitations and comorbidity with anxiety and depression].Ned Tijdschr Geneeskd. 2006 Mar 25;150(12):671-6. Ned Tijdschr Geneeskd. 2006. PMID: 16613251 Dutch.
-
[Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].Encephale. 2003 Sep-Oct;29(5):391-400. Encephale. 2003. PMID: 14615688 French.
-
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.Depress Anxiety. 2007;24(3):185-95. doi: 10.1002/da.20192. Depress Anxiety. 2007. PMID: 16900465
-
The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases.Int Clin Psychopharmacol. 1999 May;14 Suppl 2:S1-6. Int Clin Psychopharmacol. 1999. PMID: 10471166 Review.
-
Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update.Psychosom Med. 2007 Dec;69(9):860-3. doi: 10.1097/PSY.0b013e31815b0103. Psychosom Med. 2007. PMID: 18040095 Review.
Cited by
-
Anxiety and depression symptoms in chest pain patients referred for the exercise stress test.Heart Views. 2011 Oct;12(4):161-4. doi: 10.4103/1995-705X.90903. Heart Views. 2011. PMID: 22574242 Free PMC article.
-
The association between medically unexplained physical symptoms and health care use over two years and the influence of depressive and anxiety disorders and personality traits: a longitudinal study.BMC Health Serv Res. 2016 Mar 22;16:100. doi: 10.1186/s12913-016-1332-7. BMC Health Serv Res. 2016. PMID: 27125311 Free PMC article.
-
Neural correlates of somatoform disorders from a meta-analytic perspective on neuroimaging studies.Neuroimage Clin. 2016 Apr 10;11:606-613. doi: 10.1016/j.nicl.2016.04.001. eCollection 2016. Neuroimage Clin. 2016. PMID: 27182487 Free PMC article.
-
25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization.Ind Psychiatry J. 2018 Jan-Jun;27(1):87-91. doi: 10.4103/ipj.ipj_73_17. Ind Psychiatry J. 2018. PMID: 30416297 Free PMC article.
-
Diagnosis of somatoform disorders in primary care: diagnostic agreement, predictors, and comaprisons with depression and anxiety.BMC Psychiatry. 2018 Nov 12;18(1):361. doi: 10.1186/s12888-018-1940-3. BMC Psychiatry. 2018. PMID: 30419878 Free PMC article.
